Geron Corp. (GERN)
1.46
-0.09
(-5.81%)
USD |
NASDAQ |
Mar 20, 16:00
1.45
-0.01
(-0.68%)
After-Hours: 20:00
Geron Research and Development Expense (Quarterly) : 15.83M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 279.36M |
| Recursion Pharmaceuticals, Inc. | 83.34M |
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| BioMarin Pharmaceutical, Inc. | 192.41M |
| Plus Therapeutics, Inc. | 2.941M |